Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Metagenomi Therapeutics Inc (MGX)

Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Metagenomi Therapeutics Inc 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 USA

www.metagenomi.co Employees: 202 P: 510-871-4880

Sector:

Medical

Description:

Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 57,822
Enterprise Value, $K 30,432
Shares Outstanding, K 37,547
Float, K 30,864
% Float 82.20%
Short Interest, K 2,359
Short Float 6.28%
Days to Cover 8.60
Short Volume Ratio 0.29
% of Insider Shareholders 17.80%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 52,300 K
Annual Net Income, $ -78,060 K
Last Quarter Sales, $ 8,660 K
Last Quarter Net Income, $ -20,390 K
EBIT, $ -92,270 K
EBITDA, $ -94,690 K

Growth:

1-Year Return -40.64%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 11/11/25
Next Earnings Date 03/16/26
Earnings Per Share ttm -2.40
EPS Growth vs. Prev Qtr -1.85%
EPS Growth vs. Prev Year -22.22%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MGX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -43.19%
Return-on-Assets % -31.06%
Profit Margin % -149.25%
Debt/Equity 0.00
Price/Sales 1.85
Price/Cash Flow N/A
Price/Book 0.33
Book Value/Share 4.75
Interest Coverage -1.61
60-Month Beta 0.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar